Next Article in Journal
Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response
Previous Article in Journal
Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield®) in Patients with Liver Cirrhosis
 
 
Article

Article Versions Notes

Vaccines 2022, 10(11), 1838; https://doi.org/10.3390/vaccines10111838
Action Date Notes Link
article pdf uploaded. 30 October 2022 09:38 CET Version of Record https://www.mdpi.com/2076-393X/10/11/1838/pdf-vor
article supplementary file uploaded. 30 October 2022 09:38 CET - https://www.mdpi.com/2076-393X/10/11/1838#supplementary
article xml file uploaded 11 November 2022 06:44 CET Original file -
article xml uploaded. 11 November 2022 06:44 CET Update https://www.mdpi.com/2076-393X/10/11/1838/xml
article pdf uploaded. 11 November 2022 06:44 CET Updated version of record https://www.mdpi.com/2076-393X/10/11/1838/pdf
article html file updated 11 November 2022 06:46 CET Original file -
article html file updated 28 February 2023 20:40 CET Update -
article html file updated 2 March 2023 01:39 CET Update https://www.mdpi.com/2076-393X/10/11/1838/html
Back to TopTop